Status:

RECRUITING

Implementing Low-Barrier HCV Treatment in a Jail Setting

Lead Sponsor:

Lifespan

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

HEPATITIS C (HCV)

Incarceration

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and complete treatment more easily. This study fo...

Detailed Description

This is a hybrid effectiveness-implementation pilot study testing a simplified model of hepatitis C virus (HCV) treatment called MINMON-J, based on the successful "minimal monitoring" approach used in...

Eligibility Criteria

Inclusion

  • Incarcerated individual at RIDOC
  • Age ≥ 18 years
  • Awaiting trial (i.e., not sentenced)
  • English speaking
  • Diagnosis of active HCV (HCV RNA \>1000 IU/mL within 90 days prior to study entry)
  • Treatment-naïve for current HCV infection
  • No cirrhosis (FIB-4 Score \<3.25 within 90 days prior to study entry)
  • Self-report of injection drug use
  • Ability and willingness to be contacted after jail release
  • Verbal commitment to continue medication after discharge
  • Desire to receive Sofosbuvir/Velpatasvir (Epclusa)

Exclusion

  • Cirrhosis (FIB-4 Score \>3.25 within 90 days prior to study entry and/or clinical signs of cirrhosis)
  • Positive for Hepatitis B surface antigen
  • Actively pregnant or breastfeeding
  • Known allergy/sensitivity to study drug components
  • Acute or serious illness requiring hospitalization at enrollment
  • Documented severe persistent mental illness (SPMI) by RIDOC
  • Any clinical history of hepatic decompensation (e.g., ascites, SBP, HE, HRS, variceal bleeding)
  • HIV-positive with active or acute AIDS-defining opportunistic infection within 90 days

Key Trial Info

Start Date :

June 11 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2027

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06953479

Start Date

June 11 2025

End Date

August 1 2027

Last Update

July 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rhode Island Department of Corrections

Cranston, Rhode Island, United States, 02920